Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overviewAll 13F holders of TERNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of TERN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,228,726−100.0%Sold outHolders
Q1 20261,228,726$64.8M<0.1%+902,758+276.9%AddedHolders
Q4 2025325,968$13.2M<0.1%−646,804−66.5%ReducedHolders
Q3 2025972,772$7.31M<0.1%−198,847−17.0%ReducedHolders
Q2 20251,171,619$4.37M<0.1%+238,513+25.6%AddedHolders
Q1 2025933,106$2.58M<0.1%+531,448+132.3%AddedHolders
Q4 2024401,658$2.23M<0.1%+332,260+478.8%AddedHolders
Q3 202469,398$578.8K<0.1%−17,934−20.5%ReducedHolders
Q2 202487,332$594.7K<0.1%+24,563+39.1%AddedHolders
Q1 202462,769$411.8K<0.1%−45,706−42.1%ReducedHolders
Q4 2023108,475$704.0K<0.1%+86,931+403.5%AddedHolders
Q3 202321,544$108.4K<0.1%−31,531−59.4%ReducedHolders
Q2 202353,075$464.4K<0.1%+47,403+835.7%AddedHolders
Q1 20235,672$67.2K<0.1%+5,672NewHolders
Q4 20220$00.0%−3,667−100.0%Sold outHolders
Q3 20223,667$22.0K<0.1%+3,667NewHolders
Q1 20220$00.0%−3,775−100.0%Sold outHolders
Q4 20213,775$27.0K<0.1%+3,775NewHolders
Q2 20210$00.0%−2,546−100.0%Sold outHolders
Q1 20212,546$56.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.